PIPAC may reduce malignant ascites (abdominal fluid), abdominal pain and bloating in some patients, which can contribute to better quality of life.
Reduced need for fluid drainage (paracentesis) has been reported after repeated sessions. Symptom benefit does not occur in everyone, and improvement often builds over several cycles.
PIPAC is performed as a closed-system procedure with remote injection and filtered evacuation, and workplace studies have reported minimal contamination when safety protocols are followed.
Typical safety measures at specialist centers include:
Hair loss is generally uncommon with PIPAC because drug doses are low and little enters the bloodstream, although some patients notice thinning, particularly when PIPAC is combined with systemic chemotherapy.
Whether you lose hair depends on the drugs used and any other treatment you receive. Your oncologist can tell you what to expect for your regimen.
Patients who meet eligibility criteria may be able to join a PIPAC clinical trial, which can provide access to treatment and contributes to the evidence needed to assess its value.
The usual route into a clinical trial follows the steps below:
| Step | Action |
|---|---|
| 1 | Ask your oncologist whether a suitable trial exists |
| 2 | Search registries such as ClinicalTrials.gov |
| 3 | Review eligibility, visit schedule, costs and risks |
| 4 | Discuss with the trial team and give informed consent |